Axsome stock tumbled Tuesday after Axsome Therapeutics issued mixed results for its drug, Sunosi, in ADHD treatment.
A new AI model can predict the likelihood of premature death from inflammatory bowel disease (IBD) with around 95% accuracy.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Predicting Premature Deaths in Inflammatory Bowel Disease PatientsAlmost half of people who died with inflammatory bowel ...
Almost half of people who died with inflammatory bowel disease (IBD) died prematurely, according to a study published in the ...
The Dow Jones rose amid news of Trump's curbs on chip exports in the stock market today. Nvidia fell while retail stocks ...
Probiotics play a vital role in supporting the immune system by strengthening gut health, regulating inflammation, and ...